Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New results confirm that the drug, Balversa (erdafitinib), can benefit people whose tumors have a certain genetic alteration.
Balversa led to tumor regression in about a third of patients with susceptible genetic mutations.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.